DiagnoCure DiagnoCure Board Votes to Liquidate, Dissolve Company The plan, which is subject to shareholder approval, comes after the company failed to find buyers for its prostate and colorectal cancer tests. DiagnoCure's Q4 Revenues Fall as Net Loss Widens The life sciences company said the loss is mostly attributable to a decrease in royalty revenue from its PCA3 prostate cancer biomarker assets. DiagnoCure Sells PCA3 Prostate Cancer Assets to Hologic's Gen-Probe for C$6.5 Million Hologic will purchase the assets via its subsidiary Gen-Probe, from which DiagnoCure will repurchase Series A shares worth C$1 million. DiagnoCure Q1 Revenues Dip 3 Percent The firm also said that it is looking for marketing partners for its multimarker urine-based prostate cancer test, which was validated in 500 patients. In Brief This Week: Agilent Technologies; Diagnocure; KineMed, Pfizer; PositiveID; SomaLogic NEW YORK (GenomeWeb) – Agilent Technologies said this week that it has mad an adjustment to its second quarter 2014 GAAP net income. Jun 5, 2014 DiagnoCure Licenses Multi-Marker CRC Staging Test to China's Shuwen Biotech Premium Mar 20, 2014 DiagnoCure Prods Commercial Partner Hologic to Step Up Marketing for PCA3 Test or Give it Back Premium Mar 17, 2014 DiagnoCure Q1 Revenues Fall 12 Percent on Weak Sales of Hologic-marketed Prostate Cancer Assay Jun 3, 2013 DiagnoCure's Q2 Revenues Fall 85 Percent Mar 11, 2013 DiagnoCure Q1 Revenues Slide 70 Percent Jan 14, 2013 DiagnoCure Q4 Revenues Slide 59 Percent, Terminates Deal with Signal Genetics Sep 6, 2012 DiagnoCure Posts Sharp Q3 Revenue Increase; Warns It May Not Receive Payment for Services Rendered Jun 6, 2012 Payment from Gen-Probe Drives Sharp Q2 Revenue Increase for DiagnoCure Mar 30, 2012 DiagnoCure's Q1 Revenues Jump 90 Percent Sep 9, 2011 DiagnoCure's Q3 Revenues Shrink 12 Percent Aug 17, 2011 Canada Approves Gen-Probe's Prostate Cancer Assay Jul 5, 2011 Signal Genetics Gains CLIA Lab, Broadens Test Menu in $13.3M DiagnoCure Deal Premium Jun 29, 2011 Signal Genetics Inks $13.3M Deal to Commercialize DiagnoCure's Colorectal Cancer Test, Buy CLIA Lab Aug 25, 2010 DiagnoCure Retains JMP to Help with Lab Business Aug 3, 2010 DiagnoCure Laboratory Gets New York Permit Oct 5, 2009 DiagnoCure, Lab21 Ink UK Sales Pact Jun 9, 2009 DiagnoCure Cuts Q2 Loss as Revenues Drop May 1, 2009 Gen-Probe, Diagnocure Amend Prostate Cancer Test Deal Breaking News In Brief This Week: Illumina, Personalis, Proteomedix, and More Ancient DNA Details Population Dynamics Within Andean Tiwanaku Civilization Genomic Data Spanning 2K Years Gives Glimpse of Etruscan Origins, Population Changes People in the News: New Appointments at Hologic, Akoya Biosciences, Caris Life Sciences, More At NSGC, Genetic Counselors Address Race-Based Medicine, Ways to Change New Products Posted to GenomeWeb: Becton Dickinson, Cosmos-ID, OncoDNA, More The Scan US Booster Eligibility Decision The US CDC director recommends that people at high risk of developing COVID-19 due to their jobs also be eligible for COVID-19 boosters, in addition to those 65 years old and older or with underlying medical conditions. Arizona Bill Before Judge The Arizona Daily Star reports that a judge weighing whether a new Arizona law restricting abortion due to genetic conditions is a ban or a restriction. Additional Genes Wales is rolling out new genetic testing service for cancer patients, according to BBC News. Science Papers Examine State of Human Genomic Research, Single-Cell Protein Quantification In Science this week: a number of editorials and policy reports discuss advances in human genomic research, and more.